Your browser version may not work well with NCBI's Web applications. More information here...
1: J Immunol. 2007 Jan 1;178(1):122-33.
Related Articles, Links
Click here to read Click here to read
Activation of type B T cells after protein immunization reveals novel pathways of in vivo presentation of peptides.

Lovitch SB, Esparza TJ, Schweitzer G, Herzog J, Unanue ER.

Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

Type B T cells recognize a peptide-MHC conformer generated in recycling endosomes and eliminated by H2-DM in late endosomes; as a result, they recognize exogenous peptide, but fail to respond to the identical epitope generated from the native protein. To investigate the behavior of these cells in vivo, we generated mice transgenic for a type B TCR recognizing the 48-62 epitope of hen egg white lysozyme (HEL) presented by I-A(k). Type B T cells responded only to peptide ex vivo, but responded in vivo to immunization with either protein or peptide in the presence of Freund's adjuvant or LPS. Presentation of the type B conformer was MyD88-independent, evident within 24 h after HEL immunization, and restricted to the CD11b/c(+) APC subset. Immunization with listeriolysin O, a potent inducer of cell death, also primed type B T cells in vivo, and transfer of HEL-bearing allogeneic dendritic cells activated type B T cells. We conclude that a number of conditions in vivo, some of which induce inflammation and cell death, lead to peptide presentation through mechanisms distinct from the classical pathways involving H-2DM molecules.

Publication Types:
PMID: 17182547 [PubMed - indexed for MEDLINE]